Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy

Multiple sclerosis (MS) is a leading cause of chronic neurological disability in young to middle-aged adults, affecting ~2.5 million people worldwide. Currently, most therapeutics for MS are systemic immunosuppressive or immunomodulatory drugs, but these drugs are unable to halt or reverse the disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansilla, M. J., Presas-Rodríguez, S., Teniente-Serra, A., González-Larreategui, I., Quirant-Sánchez, B., Fondelli, F., Djedovic, N., Iwaszkiewicz-Grześ, D., Chwojnicki, K., Miljković, Đ., Trzonkowski, P., Ramo-Tello, C., Martínez-Cáceres, E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167140/
https://www.ncbi.nlm.nih.gov/pubmed/33958746
http://dx.doi.org/10.1038/s41423-020-00618-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167140/
https://www.ncbi.nlm.nih.gov/pubmed/33958746
http://dx.doi.org/10.1038/s41423-020-00618-z

Ejemplares similares